Kwanan nan, Jymed Fasaha Co., Ltd. ya sanar cewa Leuprorelin Acetate, wanda ya samu ta hanyar da aka samar da shi ta hanyar binciken rajistar miyagun ƙwayoyi.
Bayanin Kasuwancin Kasuwanci na asali na asali
Leuperorelin Acetate shine magungunan marasa amfani da aka yi amfani da shi don magance cututtukan hormon-Dogara, tare da tsarin dabaru C59h84n16o12 • XC2H4O2. Gonadotropin-sake fitarwa na Hormone (GNRHa) wanda yake aiki ta hanyar hana tsarin Pitubuer. Asalinsu ya kirkiro da Pharmaceutical, wannan magani an tallata karkashin sunayen alamomi daban-daban a cikin kasashe daban daban. A Amurka, ana siyar da shi a karkashin alama sunan Lupot, yayin da yake a China, an yi ta hanyar yin kasuwa kamar faɗuwar rana.
Bayyananniyar tsari da kuma ayyukan da aka ayyana
Daga shekarar 2019 zuwa 2022, an kammala binciken magunguna da cigaba na API a watan Maris 2024, lokacin da aka karbi sanarwa ta karba. An wuce binciken rajista a watan Agusta 2024. Jymed Fasaha Co., Ltd. yana da alhakin ci gaban aiwatarwa, ci gaban hanya, nazarin tsarin, da kuma ingancin tsarin, da kuma ingancin tsarin, da kuma ingancin tsarin, da ingantacciyar hanyar tsari. HubeI na JX Bio-Pharmacetical Co., Ltd. ya kasance mai lura da ingancin ingancin tsarin, ingantaccen tsarin hanyar shakatawa, da kuma nazarin kwanciyar hankali, da kuma karatun zaman lafiya ga API.
Fadada Kasuwa da Buƙatar Bukatar
Rushewar mahaifa da fibroids na ciki yana tuki da karuwar buƙatun leuprorelin halletate. Kasuwar Amurka ta Arewa a halin yanzu tana mamakin kasuwar Acetorate, tare da haɓaka kashe kiwon lafiya da kuma babban yarda da sabbin fasahohi kasancewa direbobi na farko. Lokaci guda, kasuwar Asiya, musamman China, ita ma tana nuna kyakkyawar buƙata don Leprorelin Acetate. Due to its effectiveness, global demand for this drug is on the rise, with the market size expected to reach USD 3,946.1 million by 2031, reflecting a compound annual growth rate (CAGR) of 4.86% from 2021 to 2031.
Game da jymed
Shenzhen Jyed Fasaha Co., Ltd. (na daga nan eninfst an kafa shi a cikin 2009, ƙwarewa a cikin binciken, ci gaba, samarwa, da kuma sayar da abinci da kayayyakin peptide. Tare da cibiyar bincike guda ɗaya da manyan tushen masana'antu, joymed yana daya daga cikin manyan masu samar da kayan kwalliya na APPID APT a China. Kamfanin kamfanin Kamfanin na Kamfanin ya yi alfahari da shekaru 20 na gogewa a cikin masana'antar abinci kuma ya samu nasarar aiwatar da FDA sau biyu. Cikakken tsarin masana'antar jymed.
Babban ayyukan kasuwanci
1.Daga Rajistar cikin rajista na kasa da Apptide Apis
2. ACERE DA TAFIYA
3.Toustom peptides da Cro, CMO, OEM aiyukan
4.PDC kwayoyi (peptide-radionuclide, peptide-kananan kwayoyin, peptide-furotin, peptide-rna)
Baya ga Leuperorelin Aceporate, Jymed ya ƙaddamar da matatun rajista tare da FDA na yanzu don magungunan Glp-1 na Semaglutide, Lira da Tirzeptaide. Abokan ciniki masu zuwa na gaba suna amfani da samfuran Jymed nan gaba za su iya yin lambar lambar rajista ko lambar fayil ɗin DMF lokacin ƙaddamar da aikace-aikacen rajista zuwa FDA ko CDE. Wannan zai rage yawan da ake buƙata don shirya takaddun aikace-aikacen, da kuma lokacin kimantawa da farashin bita na samfurin.
Tuntube mu
Shenzhen Jyed Fasaha Co., Ltd.
Adireshin:8th&9th Floors, Building 1, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen
Waya:+86 755-26612112
Yanar gizo:http://www.jymech.com/
Lokaci: Aug-29-2024
